METHOXSALEN Drug Patent Profile
✉ Email this page to a colleague
When do Methoxsalen patents expire, and what generic alternatives are available?
Methoxsalen is a drug marketed by Actavis Inc, Ani Pharms, and Strides Pharma. and is included in three NDAs.
The generic ingredient in METHOXSALEN is methoxsalen. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methoxsalen
A generic version of METHOXSALEN was approved as methoxsalen by STRIDES PHARMA on June 5th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHOXSALEN?
- What are the global sales for METHOXSALEN?
- What is Average Wholesale Price for METHOXSALEN?
Summary for METHOXSALEN
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 150 |
| Clinical Trials: | 25 |
| Patent Applications: | 5,475 |
| Drug Prices: | Drug price information for METHOXSALEN |
| What excipients (inactive ingredients) are in METHOXSALEN? | METHOXSALEN excipients list |
| DailyMed Link: | METHOXSALEN at DailyMed |
Recent Clinical Trials for METHOXSALEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Georgetown University | Phase 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Sarcoma Oncology Research Center, LLC | Phase 2 |
Pharmacology for METHOXSALEN
| Drug Class | Photoactivated Radical Generator Psoralen |
| Mechanism of Action | Photoabsorption |
| Physiological Effect | Photosensitizing Activity |
Medical Subject Heading (MeSH) Categories for METHOXSALEN
Anatomical Therapeutic Chemical (ATC) Classes for METHOXSALEN
US Patents and Regulatory Information for METHOXSALEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Inc | METHOXSALEN | methoxsalen | CAPSULE;ORAL | 202603-001 | Jun 9, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | METHOXSALEN | methoxsalen | CAPSULE;ORAL | 087781-001 | Jun 8, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Strides Pharma | METHOXSALEN | methoxsalen | CAPSULE;ORAL | 202687-001 | Jun 5, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
